CMSC update on the Annual Meeting and COVID-19

CMSC update on the Annual Meeting and COVID-19

As part of our commitment to ensuring healthy lives and promote well-being, we are providing you a list of resources related to coronavirus (COVID-19).

A live-tracker of the spread of the disease from Johns Hopkins University.
The latest updates from the WHO on the virus.
WHO’s recommendations for the public to reduce exposure.
The Center for Disease Control’s (CDC) recommendations for traveling.
WHO’s rolling updates on coronavirus disease (COVID-19).

We are currently preparing systems and processes to be put in place to manage this issue during the meeting. More detailed information will be posted on our website as soon as we have them confirmed.

We will continue to monitor the situation and will update you on any changes regarding the 2020 CMSC Annual Meeting.

Elizabeth Porco

In memoriam: Barry GW Arnason, MD, FAAN

Abstracts for CMSC 2023 Annual Meeting reflect multidisciplinary multiple sclerosis research

CMSC 2023 Annual Meeting program offers cutting-edge science & clinical skill updates

NeurologyLive® and CMSC announce Giants of Multiple Sclerosis® 2023 class of inductees

CMSC PR, Partners

CMSC announces new initiatives to address disparities and inequality in multiple sclerosis care

CMSC 2023 Annual Meeting offers latest updates in multiple sclerosis diagnosis, treatment & research

In memoriam Dr. Jack S. Burks

In memory of Dr. George Kraft

In memoriam Peter Wade, MD

NeurologyLive® announces the inaugural Giants of Multiple Sclerosis™ Program

CMSC PR, Partners

NeurologyLive® & the CMSC launches MS Cure Connections® Video Series

CMSC PR, Partners

NeurologyLive® and CMSC partner to present two expert-driven webcast programs

WHO and AMA statement

Advocacy, CMSC PR, MS Community, Partners

A position statement in 2020: a year of turmoil

Advocacy, CMSC PR

In memoriam Susan E. Bennett, PT, DPT, EdD, NCS, MSCS

In memoriam: Elaine Whitaker

Coronavirus and multiple sclerosis reporting database announced by CMSC & NMSS

Coronavirus and multiple sclerosis reporting database

CMSC PR, Partners

CMSC Annual Meeting, May 27-30, 2020 in Orlando, FL announces cancellation

CMSC update on COVID-19: NMSS National Medical Advisory Committee recommendations

CMSC PR, Partners

Multiple sclerosis and COVID-19 registry

CMSC PR, Partners

CMSC announces four winners of Pilot Research Awards for 2019

In Memoriam: Alan Mandel

Janet Brown obituary

CMSC opens weeklong mental health program to help mentor and train multiple sclerosis specialists

CMSC PR, Partners

CMSC, multiple sclerosis non-profits and Polar Products recognizes over twenty years of progress

CMSC PR, Partners

June Halper outlines the biggest management challenges in multiple sclerosis

In memoriam: Dr. Conomy, a founder and former Executive Director of the CMSC

In memoriam of Dr. Lael Stone

Our condolences to the family of Nicola “Nicki” Ward-Abel, RGN, BSc (Hons), MSCN

TREAT-MS

CMSC PR, Partners

Press Release – CMSC receives Interprofessional Continuing Education Joint Accreditation

National Multiple Sclerosis Society endorses multiple sclerosis “NARCRMS” data registry

CMSC PR, INforMS, Partners

Patients tell their stories in Consortium of Multiple Sclerosis Centers’ online videos

CMSC PR, MS Community

International Journal of Multiple Sclerosis Care wins 2017 APEX Award

CMSC PR, Partners

Consortium announces new multiple sclerosis Physician Assistant special interest group

CMSC revises recommendations for Gadolinium use in MRIs

CMSC 2017 Annual Meeting – Ocrevus, progressive multiple sclerosis and other research highlights

Acne therapy reduces rate of multiple sclerosis progression, Canadian study reports

CMSC 2017 Annual Meeting – caregivers of multiple sclerosis patients say the disease exhausts physically & emotionally

CMSC 2017 Annual Meeting – Ocrevus lowers multiple sclerosis relapse rates even further in extension study

CMSC 2017 Annual Meeting – physical activity halts depression in young multiple sclerosis patients, Canadian study shows

CMSC 2017 Annual Meeting – Celgene’s investigational therapy Ozanimod safe, effective in treating RMS

CMSC PR, Partners

CMSC 2017 Annual Meeting – Rituxan-treated multiple sclerosis patients three times more likely to have improved brain scans

CMSC PR, Partners

CMSC 2017 Annual Meeting – Cladribine reduced annual multiple sclerosis relapse rate by 55% to 57%, trials show

CMSC 2017 Annual Meeting – review suggests certain multiple sclerosis patient groups may discontinue DMTs

CMSC PR, Partners

CMSC 2017 Annual Meeting – Tysabri improves mental outlook for patients with secondary progressive MS

CMSC PR, Partners

CMSC 2017 Annual Meeting – feeling of social stigma makes depression in multiple sclerosis more likely, study reports

CMSC 2017 Annual Meeting – multiple sclerosis patients should contribute to outcome measure development, study argues

CMSC PR, Partners

CMSC 2017 Annual Meeting – multiple sclerosis mobile apps link clinicians and patients, improving disease management

CMSC 2017 Annual Meeting – relapse after first Lemtrada course no indication of poor long-term outcome

CMSC 2017 Annual Meeting – single session of ball-throwing exercise improves balance control in multiple sclerosis

CMSC PR, Partners

CMSC 2017 Annual Meeting – Genentech starts site to connect multiple sclerosis patients and caregivers with resources

CMSC PR, Partners

CMSC 2017 Annual Meeting – all about teamwork in multiple sclerosis

CMSC PR, Partners

CMSC 2017 Annual Meeting – experts to focus on multiple sclerosis patient care at CMSC Annual Meeting in New Orleans

CMSC PR, Partners

In memoriam – Dr. William Sheremata

Stress and MS: Webinar from IOMSN helps manage daily stress

LiveWiseMS – a new online resource for people with multiple sclerosis

Consortium of Multiple Sclerosis Centers calls for abstracts for CMSC 2017 Annual Meeting

United Spinal Association offering range of materials at exhibit booth at CMSC 2016 Annual Meeting

CMSC PR, Partners

In memoriam – Dr. Omar Khan

Multiple sclerosis rehabilitation specialist, Susan Bennett, receives CMSC Lifetime Achievement Award

CMSC PR, Partners

CMSC 2016 Annual Meeting – Clay Walker’s concert at the CMSC 30th anniversary celebration

CMSC PR, Partners

CMSC 2016 Annual Meeting – Multiple Sclerosis News Today’s exclusive interview with Mark Freedman

CMSC PR, Partners

CMSC 2016 Annual Meeting – Multiple Sclerosis News Today’s exclusive interview with Summer Kernan

CMSC PR, Partners

Nine CMSC 2016 Annual Meeting exclusive interviews you can’t miss

CMSC PR, Partners

CMSC 2016 Annual Meeting – metabolism in multiple sclerosis and the role of mitochondrial dysfunction

CMSC 2016 Annual Meeting – tai chi shown to improve balance and strength in multiple sclerosis patients

CMSC 2016 Annual Meeting – multiple sclerosis rehab clinical practice guideline help patients achieve excellent results

CMSC 2016 Annual Meeting – multiple sclerosis patients’ speech limitations and difficulty in swallowing may be measured

CMSC 2016 Annual Meeting – aging multiple sclerosis patients experience greater physical dysfunction

CMSC 2016 Annual Meeting – physical training with assistive devices improves mobility for multiple sclerosis patients

CMSC 2016 Annual Meeting – Fingolimod (Gilenya) offers consistent health benefits in RRMS patients

CMSC PR, Partners

CMSC 2016 Annual Meeting – multiple sclerosis mice show reduced disease severity after treatment with vegetable compound

CMSC 2016 Annual Meeting – multiple sclerosis patients, physical therapists have distinct decision-making processes

CMSC PR, Partners

CMSC 2016 Annual Meeting – home DVD-guided exercise may help older multiple sclerosis patients

CMSC 2016 Annual Meeting – multiple sclerosis duration and disability level variously impacts arm function

CMSC PR, Partners

CMSC 2016 Annual Meeting – multiple sclerosis and yoga: author and instructor says ancient discipline can help patients

CMSC PR, Partners

CMSC 2016 Annual Meeting – Ocrevus (Ocrelizumab) in PPMS prevented disability progression

CMSC PR, Partners

CMSC 2016 Annual Meeting – Genentech’s Ocrelizumab a promising therapy for primary progressive multiple sclerosis

CMSC 2016 Annual Meeting – RRMS patients’ five-year clinical outcome improved – find out how

CMSC 2016 Annual Meeting – strive study confirms Tysabri safety in early relapsing-remitting multiple sclerosis

CMSC 2016 Annual Meeting – RRMS patients on Alemtuzumab (Lemtrada) show slowed disability progression

CMSC 2016 Annual Meeting – delayed-release Dimethyl Fumarate benefits newly diagnosed multiple sclerosis patients

CMSC 2016 Annual Meeting – stem cell transplants – an exciting multiple sclerosis therapy development

CMSC 2016 Annual Meeting – multiple sclerosis patients of African descent may fare better on Alemtuzumab (Lemtrada)

CMSC 2016 Annual Meeting – multiple sclerosis care should include fatigue, sleep quality and inattentiveness assessment

CMSC 2016 Annual Meeting – multiple sclerosis research highlights what improves with clinical care

CMSC 2016 Annual Meeting– assessing/treating psychiatric disorders in multiple sclerosis patients may improve prognosis

CMSC 2016 Annual Meeting – hispanic multiple sclerosis patients featured in film to promote health, self-care

CMSC 2016 Annual Meeting – fatigue in multiple sclerosis might be handled with interactive self-management resource

CMSC 2016 Annual Meeting – multiple sclerosis patients at higher risk for loneliness, study shows

CMSC 2016 Annual Meeting – exclusive interview with Dr. Rosalind Kalb on multiple sclerosis care and family involvement

CMSC 2016 Annual Meeting – study aims to improve multiple sclerosis care by considering patients’ perspectives

CMSC PR, Uncategorized

CMSC 2016 Annual Meeting – women with multiple sclerosis have significant depression, fatigue, decline in cognitive function

CMSC 2016 Annual Meeting – new screening tool for swallowing difficulties in multiple sclerosis evaluated

CMSC 2016 Annual Meeting – sexual dysfunction in hispanic multiple sclerosis patients exists with other issues, study

CMSC 2016 Annual Meeting – medical affairs vice president at EMD Serono discusses multiple sclerosis drug rebif, Multiple Sclerosis LifeLines

CMSC PR, Partners

CMSC 2016 Annual Meeting – lifestyle factors and unconventional medicine in multiple sclerosis care

CMSC 2016 Annual Meeting – Multiple Sclerosis News Today’s exclusive interview with June Halper

CMSC 2016 Annual Meeting – multiple sclerosis expert Fred Lublin discusses relevance of multiple sclerosis relapses

CMSC 2016 Annual Meeting – Patricia Coyle, a multiple sclerosis expert, talks about Vitamin D, fatigue & other issues

CMSC 2016 Annual Meeting – Multiple Sclerosis News Today to provide on-site coverage of annual meeting

4 reasons for multiple sclerosis patients to keep track of the CMSC 2016 Annual Meeting

CMSC congratulates Kessler Foundation for this prestigious recognition

CMSC PR, Partners

CMSC 2016 Annual Meeting final program

Dr. Ellen Mowry, in Interview, talks of clinical studies for Vitamin D & multiple sclerosis

CMSC PR, Partners

Scientific abstracts for the CMSC 2016 Annual Meeting

High glutamate levels in brain seen to drive multiple sclerosis progression

CMSC PR, Partners

CMSC 2016 Annual Meeting agenda

CMSC 2016 Annual Meeting goals and highlights

CMSC 2016 Annual Meeting – multiple sclerosis experts agree on benefits of Vitamin D supplements

CMSC 2016 Annual Meeting – Dr. Fred Lublin opening lecture on multiple sclerosis relapses and impact on patient outcome

CMSC 2016 Annual Meeting – an interview with June Halper, the Consortium’s CEO and a multiple sclerosis Nurse Practitioner

In memoriam – Toni Chiara

In memoriam – Dr. Rossman

John F. Kurtzke, MD, remembered

CMSC issues position statement on Aaccess to medications to treat symptoms of multiple sclerosis

Multiple Sclerosis Coalition announces new board President

CMSC PR, Partners

The latest in multiple sclerosis care & research to be presented at educational conference for healthcare professionals

CMSC announces a virtual support group for multiple sclerosis patients

Optimizing multiple sclerosis management – new CME/CE courses for healthcare professionals

CMSC PR, Partners

CMSC announces new President & board members

AIMS presents the latest on multiple sclerosis treatments

CMSC PR, Partners

Psychology continuing education credit offered at multiple sclerosis conference

Record attendance at the cooperative meeting of CMSC & ACTRIMS

Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/31/2014

Workforce of the Future spotlighted at multiple sclerosis conference

Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/30/2014

Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/29/2014

EMD Serono data at CMSC & ACTRIMS Annual Meeting reinforces proven efficacy of rebif

CMSC PR, Partners

Media alert — grow your multiple sclerosis knowledge

Acorda Therapeutics to showcase online multiple sclerosis resources at 2014 CMSC/ACTRIMS meeting

CMSC PR, Partners

Leading multiple sclerosis conference offers continuing education credit for pharmacists

Top multiple sclerosis experts headline conference focused on comprehensive approach to care

New continuing education program helps distinguish between primary care needs & multiple sclerosis symptoms

CMSC PR, Partners

CMSC launches new mental health special interest group (MS-MHP)

Comments are closed.